US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ashland

50.48

+0.93001.88%

Post-market: 50.480.00000.00%16:07 EDT

Volume:404.29K

Turnover:20.42M

Market Cap:2.38B

PE:-110.09

High:50.98

Open:49.91

Low:49.73

Close:49.55

Loading ...

Overview Company News Filings

Genmab to Hold 2024 R&D Update and ASH Data Review Meeting

Ashland Inc : Wells Fargo Cuts Target Price to $90 From $95

THOMSON REUTERS

Perseus Proteomics Presents PPMX-T003 Phase I Trial Results at ASH Meeting

MT Newswires Live

Omeros Corp (OMER): Profit-Taking Time Amid ASH Presentations and Financial Challenges

Immix Biopharma Announces 75% Complete Response Rate (n=16); 31.5 months Best Response Duration (ongoing) for CAR-T NXC-201 in Relapsed/Refractory AL Amyloidosis Patients at ASH 2024

Geron Announces New IMerge Analyses Presented at ASH Suggesting Clinical Activity of RYTELO™ (imetelstat) in Patients with Lower-Risk MDS Regardless of Type or Number of Prior Therapies

Geron Announces Phase 1 Findings from Two-Part IMproveMF Study Presented at ASH Suggesting Tolerability of RYTELO™ (imetelstat) in Combination with Ruxolitinib as Frontline Therapy in Patients with Myelofibrosis

Omeros Corporation Announces Presentation of Positive Zaltenibart Data at ASH Annual Meeting

Bionano Announces Presentations at the American Society of Hematology (ASH) Annual Meeting that Underscore OGM Utility Across Blood Cancer Research and Cell & Gene Therapy

Subdued Growth No Barrier To Ashland Inc.'s (NYSE:ASH) Price

Simply Wall St.

IN8bio Reports Continued Progression-Free Survival in Phase 1 Investigator-Sponsored Trial of INB-100 Allogeneic Gamma-Delta T Cells for Leukemias at the 2024 American Society of Hematology Annual Meeting

Clinical trial data for MF candidate proves promising for Syntara

The Market Herald

Metagenomi presents updated preclinical data in Hemophilia A at ASH

Metagenomi Presents Updated Preclinical Data in Hemophilia A at American Society of Hematology (ASH) 66th Annual Meeting

Lyell Presents Positive Initial Clinical Data from the Phase 1-2 Clinical Trial of IMPT-314 for the Treatment of B-cell Lymphoma at the 2024 ASH Annual Meeting

BeiGene discloses new data in BRUKINSA, promising advancements pipeline at ASH

Keros Therapeutics presents clinical data from Elritercept program at ASH

Genentech presents updated fixed-duration Columvi and Lunsumio data at ASH

Autolus Therapeutics presents clinical data updates at ASH meeting

Is Ashley Services Group (ASX:ASH) A Risky Investment?

Simply Wall St.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ASH/news?page=7"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ASH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ASH\",,,,,undefined,":{"symbol":"ASH","market":"US","secType":"STK","nameCN":"Ashland","latestPrice":50.48,"timestamp":1744920000000,"preClose":49.55,"halted":0,"volume":404291,"hourTrading":{"tag":"盘后","latestPrice":50.48,"preClose":50.48,"latestTime":"16:07 EDT","volume":15308,"amount":772747.84,"timestamp":1744920471689},"delay":0,"floatShares":46615360,"shares":47182862,"eps":-0.458541,"marketStatus":"Market Closed","change":0.93,"latestTime":"04-17 16:00:00 EDT","open":49.91,"high":50.98,"low":49.725,"amount":20420541.548092,"amplitude":0.025328,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.458541,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1745222400000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NYSE","adjPreClose":49.55,"dividendRate":0.031696,"preHourTrading":{"tag":"盘前","latestPrice":49.55,"preClose":49.55,"latestTime":"08:02 EDT","volume":10,"amount":492.04998,"timestamp":1744891342185},"postHourTrading":{"tag":"盘后","latestPrice":50.48,"preClose":50.48,"latestTime":"16:07 EDT","volume":15308,"amount":772747.84,"timestamp":1744920471689},"volumeRatio":0.672300055897583,"impliedVol":0.5279,"impliedVolPercentile":0.9562},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ASH\",,,,,undefined,":{"symbol":"ASH","floatShares":46615360,"roa":"1.94%","roe":"0.18%","lyrEps":3.448979,"volumeRatio":0.672300055897583,"shares":47182862,"dividePrice":1.6,"high":50.98,"amplitude":0.025328,"preClose":49.55,"low":49.725,"week52Low":45.21,"pbRate":"0.92","psRate":"1.16","week52High":102.5,"institutionHeld":0.8513,"latestPrice":50.48,"eps":-0.458541,"divideRate":0.031696,"volume":404291,"delay":0,"ttmEps":-0.458541,"open":49.91,"prevYearClose":71.46,"prevWeekClose":50.51,"prevMonthClose":59.29,"prevQuarterClose":59.29,"fiveDayClose":48.59,"twentyDayClose":55.87,"sixtyDayClose":70.63,"earningDate":1745942400000,"earningTime":"盘后"},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ASH\",pageSize:20,pageCount:7,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2490540608","title":"Genmab to Hold 2024 R&D Update and ASH Data Review Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2490540608","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490540608?lang=en_us&edition=fundamental","pubTime":"2024-12-11 21:20","pubTimestamp":1733923200,"startTime":"0","endTime":"0","summary":"Media Release Event to be held virtually via live webcast and archived on www.genmab.com Copenhagen, Denmark; December 11, 2024 – Genmab A/S (Nasdaq: GMAB) will hold its 2024 R&D Update and ASH Data R","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/12/11/2995389/0/en/Genmab-to-Hold-2024-R-D-Update-and-ASH-Data-Review-Meeting.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2463526074.USD","ASH","BK4109"],"gpt_icon":0},{"id":"2490865854","title":"Ashland Inc : Wells Fargo Cuts Target Price to $90 From $95","url":"https://stock-news.laohu8.com/highlight/detail?id=2490865854","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490865854?lang=en_us&edition=fundamental","pubTime":"2024-12-11 21:14","pubTimestamp":1733922880,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241211:nFWN3NC17D:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ASH","BK4109","LU2463526074.USD"],"gpt_icon":0},{"id":"2490737460","title":"Perseus Proteomics Presents PPMX-T003 Phase I Trial Results at ASH Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2490737460","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490737460?lang=en_us&edition=fundamental","pubTime":"2024-12-11 07:37","pubTimestamp":1733873842,"startTime":"0","endTime":"0","summary":"Perseus Proteomics  presented phase I results of its anti-TfR1 antibody, PPMX-T003, at the 66th ASH Annual Meeting, according to a Tuesday filing on the Tokyo Stock Exchange.The trial, conducted with six polycythemia vera patients, showed no serious adverse effects and demonstrated efficacy, with five patients completing 12 weeks without phlebotomy, the filing said.The company is also developing other antibody therapies for cancer.Price : $742.00, Change: $+22, Percent Change: +3.06%","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ASH","LU2463526074.USD","BK4109"],"gpt_icon":0},{"id":"2490414530","title":"Omeros Corp (OMER): Profit-Taking Time Amid ASH Presentations and Financial Challenges","url":"https://stock-news.laohu8.com/highlight/detail?id=2490414530","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490414530?lang=en_us&edition=fundamental","pubTime":"2024-12-11 01:22","pubTimestamp":1733851350,"startTime":"0","endTime":"0","summary":"We recently published a list of Jim Cramer’s Lightning Rounds: 12 Stocks Under the Spotlight. In this article, we are going to take a look at where Omeros Corporation  stands against other stocks under Jim Cramer's lightning rounds' spotlight.Jim Cramer, host of Mad Money, recently discussed the outlook for the stock market following a year of strong gains, cautioning that investors’ overly optimistic expectations for Federal Reserve rate cuts could lead to trouble. As the year draws to a close, brokerages are releasing their official market predictions for 2025, and so far, they are almost universally positive.He said that this optimism is understandable given the strong earnings season and the significant stock market rally following the election. Cramer noted that many investors are betting that a business-friendly administration will continue to drive better returns.For this article, we compiled a list of 12 stocks that were discussed by Jim Cramer during recent episodes of Mad Mon","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/PzgWkUedCz5KdZjbTR3fkA--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/53298a11f85c876aabe6ac8c5856e2a7","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/PzgWkUedCz5KdZjbTR3fkA--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/53298a11f85c876aabe6ac8c5856e2a7"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/omeros-corp-omer-profit-taking-172230938.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["US5Y.BOND",".IXIC","LU2463526074.USD","MNQmain","ASH","QID","US10Y.BOND","US12M.BOND","QLD","US30Y.BOND","US2Y.BOND","TQQQ","US7Y.BOND","SQQQ","PSQ","NQmain","US3Y.BOND","US6M.BOND","BK4109","OMER","BK4007"],"gpt_icon":1},{"id":"2490301924","title":"Immix Biopharma Announces 75% Complete Response Rate (n=16); 31.5 months Best Response Duration (ongoing) for CAR-T NXC-201 in Relapsed/Refractory AL Amyloidosis Patients at ASH 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2490301924","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490301924?lang=en_us&edition=fundamental","pubTime":"2024-12-10 22:39","pubTimestamp":1733841540,"startTime":"0","endTime":"0","summary":"Immix Biopharma, Inc. (Nasdaq:IMMX)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/12/10/2994665/0/en/Immix-Biopharma-Announces-75-Complete-Response-Rate-n-16-31-5-months-Best-Response-Duration-ongoing-for-CAR-T-NXC-201-in-Relapsed-Refractory-AL-Amyloidosis-Patients-at-ASH-2024.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B19Z6F94.USD","NXC","IE00B7SZL793.SGD","BK4109","BK4022","IE0031619046.USD","BK4183","IE00B19Z4B17.USD","BK4113","LU2463526074.USD","BK4104","BK4230","CAR","BK4572","CRS","BK4588","CR","IE0034390439.USD","CART","BK4161","AL","ASH","IE00B66KJ199.SGD","BK4585","ODD","BK4006"],"gpt_icon":0},{"id":"2490697017","title":"Geron Announces New IMerge Analyses Presented at ASH Suggesting Clinical Activity of RYTELO™ (imetelstat) in Patients with Lower-Risk MDS Regardless of Type or Number of Prior Therapies","url":"https://stock-news.laohu8.com/highlight/detail?id=2490697017","media":"Business Wire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490697017?lang=en_us&edition=fundamental","pubTime":"2024-12-10 22:00","pubTimestamp":1733839200,"startTime":"0","endTime":"0","summary":"Analyses pooling data from IMerge Phase 2, Phase 3 and the QTc substudy suggest patients who were ESA ineligible or who had prior treatment with luspatercept or lenalidomide experienced clinical benefit from imetelstat similar to prior results from the IMerge pivotal trial. Data from the QTc substudy reinforce imetelstat as a second-line treatment option for LR-MDS patients with transfusion-dependent anemia regardless of prior therapies, including luspatercept and lenalidomide. A patient-reported outcome analysis from IMerge Phase 3 showed sustained improvement in fatigue and maintenance of quality of life and anemia symptoms with imetelstat compared with placebo. \"These latest IMerge analyses presented at ASH contribute to a growing body of clinical evidence that support RYTELO as a second-line option in red blood cell transfusion-dependent lower-risk MDS, regardless of prior treatments,\" said Faye Feller, M.D., Executive Vice President, Chief Medical Officer of Geron. \"Additionally, ","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/1V7XSYPBUCB0SLyyhvt_Zg--~B/aD01MTI7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/54e4baed5caed97e924b0196cfaf6ce0","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/1V7XSYPBUCB0SLyyhvt_Zg--~B/aD01MTI7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/54e4baed5caed97e924b0196cfaf6ce0"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/geron-announces-imerge-analyses-presented-140000921.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2463526074.USD","ASH","GERN","RS","HMA","BK4006","BK4109","BK4139"],"gpt_icon":0},{"id":"2490176110","title":"Geron Announces Phase 1 Findings from Two-Part IMproveMF Study Presented at ASH Suggesting Tolerability of RYTELO™ (imetelstat) in Combination with Ruxolitinib as Frontline Therapy in Patients with Myelofibrosis","url":"https://stock-news.laohu8.com/highlight/detail?id=2490176110","media":"Business Wire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490176110?lang=en_us&edition=fundamental","pubTime":"2024-12-10 22:00","pubTimestamp":1733839200,"startTime":"0","endTime":"0","summary":"In the dose escalation Part 1 of the study, no dose-limiting toxicities were observed and the PK profiles were similar to those reported for previous monotherapy studies of imetelstat and ruxolitinib. Based on the safety profile, imetelstat 9.4 mg/kg dosed every four weeks with ruxolitinib was the selected dose for the dose expansion Part 2 of the study, which is currently enrolling patients. \"Upon diagnosis, intermediate-1 and -2 and high-risk myelofibrosis patients typically receive ruxolitinib as the primary therapy, which reduces enlarged spleens and alleviates symptoms. These early results showing the tolerability of ruxolitinib combined with imetelstat in this patient population are highly encouraging, because as a non-JAK inhibitor treatment option with a potentially novel mechanism of action, imetelstat could provide an additive benefit, affecting the underlying malignant clones implicated in MF progression, when combined with ruxolitinib alone,\" said John Mascarenhas, M.D., Pr","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/pWJZ1mBrontFIBsPmSBvIQ--~B/aD01MTI7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/552cac5071faa71fd5f09cac7f030e72","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/pWJZ1mBrontFIBsPmSBvIQ--~B/aD01MTI7dz0xMDI0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/552cac5071faa71fd5f09cac7f030e72"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/geron-announces-phase-1-findings-140000504.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4539","BK4181","BK4526","BK4225","PK","BK4139","MF","BK4218","GERN","BK4563","BK4203","LU2463526074.USD","BK4113","ASH","HR","BK4109","TSS"],"gpt_icon":0},{"id":"2490701532","title":"Omeros Corporation Announces Presentation of Positive Zaltenibart Data at ASH Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2490701532","media":"Business Wire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490701532?lang=en_us&edition=fundamental","pubTime":"2024-12-10 21:45","pubTimestamp":1733838300,"startTime":"0","endTime":"0","summary":"-- Clinical Trial and Clinical Pharmacology Data Support Upcoming Enrollment of Omeros’ Zaltenibart Phase 3 Clinical Program in PNH --. SEATTLE, December 10, 2024----Omeros Corporation  today announced that two posters directed to zaltenibart , Omeros’ investigational inhibitor of MASP-3, the key and most proximal activator of the alternative pathway of complement, were presented at the 66th Annual Meeting of the American Society of Hematology  yesterday in San Diego. The posters, both addressing zaltenibart in paroxysmal nocturnal hemoglobinuria  – a rare, life-threatening hematological disorder – detail positive Phase 2 clinical data and clinical pharmacology analyses supporting zaltenibart dose selection for the PNH Phase 3 program. Enrollment for the zaltenibart Phase 3 clinical trials in PNH is expected to open in early 2025.Zaltenibart  is an investigational human monoclonal antibody targeting mannan-binding lectin-associated serine protease-3 , the key and most proximal activato","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/f1eohffvki86vEm7rHdNnw--~B/aD0zNDI7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/bdb0af314a40b16a2dd3479ea9b7b5bc","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/f1eohffvki86vEm7rHdNnw--~B/aD0zNDI7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/bdb0af314a40b16a2dd3479ea9b7b5bc"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/omeros-corporation-announces-presentation-positive-134500512.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4109","LU2463526074.USD","BK4007","ASH","OMER"],"gpt_icon":0},{"id":"2490018213","title":"Bionano Announces Presentations at the American Society of Hematology (ASH) Annual Meeting that Underscore OGM Utility Across Blood Cancer Research and Cell & Gene Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2490018213","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490018213?lang=en_us&edition=fundamental","pubTime":"2024-12-10 21:00","pubTimestamp":1733835600,"startTime":"0","endTime":"0","summary":"Thirteen scientific posters feature results from OGM applications in myeloid cancers, acute lymphoblastic leukemia (ALL), myelodysplastic syndromes (MDS), lymphoma, and other hematological malignancy ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/12/10/2994491/0/en/Bionano-Announces-Presentations-at-the-American-Society-of-Hematology-ASH-Annual-Meeting-that-Underscore-OGM-Utility-Across-Blood-Cancer-Research-and-Cell-Gene-Therapy.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","BK4109","LU2463526074.USD","LU2355687059.USD","BK4117","ITP","LU0985320562.USD","LU1699723380.USD","ALL","BK4107","BK4585","ASH","BK4199","AFG","BK4533","LU1571399168.USD"],"gpt_icon":0},{"id":"2490336041","title":"Subdued Growth No Barrier To Ashland Inc.'s (NYSE:ASH) Price","url":"https://stock-news.laohu8.com/highlight/detail?id=2490336041","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490336041?lang=en_us&edition=fundamental","pubTime":"2024-12-10 20:15","pubTimestamp":1733832901,"startTime":"0","endTime":"0","summary":"There wouldn't be many who think Ashland Inc.'s ( NYSE:ASH ) price-to-earnings (or \"P/E\") ratio of 18.1x is worth a...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/2024000-choice2-main-header/1585186739035","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2024000-choice2-main-header/1585186739035"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/materials/nyse-ash/ashland/news/subdued-growth-no-barrier-to-ashland-incs-nyseash-price","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["NYSE","ASH","BK4109","LU2463526074.USD"],"gpt_icon":0},{"id":"2490094419","title":"IN8bio Reports Continued Progression-Free Survival in Phase 1 Investigator-Sponsored Trial of INB-100 Allogeneic Gamma-Delta T Cells for Leukemias at the 2024 American Society of Hematology Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2490094419","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490094419?lang=en_us&edition=fundamental","pubTime":"2024-12-10 20:00","pubTimestamp":1733832000,"startTime":"0","endTime":"0","summary":"INB-100 continues to demonstrate durable complete remissions (CR) with no relapses observed in any acute myeloid leukemia (AML) patients including those with high-risk disease after a median follow-up","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/12/10/2994365/0/en/IN8bio-Reports-Continued-Progression-Free-Survival-in-Phase-1-Investigator-Sponsored-Trial-of-INB-100-Allogeneic-Gamma-Delta-T-Cells-for-Leukemias-at-the-2024-American-Society-of-H.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRS","BK4107","HSCT","BK4006","INAB","BK4539","BK4109","AFG","INB","IE0031619046.USD","IE00B19Z4B17.USD","IE00B7SZL793.SGD","RIC","BK4117","CR","LU2463526074.USD","BK4161","IE00B66KJ199.SGD","BK4139","ASH"],"gpt_icon":0},{"id":"2490051521","title":"Clinical trial data for MF candidate proves promising for Syntara","url":"https://stock-news.laohu8.com/highlight/detail?id=2490051521","media":"The Market Herald","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490051521?lang=en_us&edition=fundamental","pubTime":"2024-12-10 13:08","pubTimestamp":1733807280,"startTime":"0","endTime":"0","summary":"Syntara Ltd  has reported interim data from a trial to assess the efficacy of its drug candidate for treatment of myelofibrosis , with results showing that the candidate – SNT-5505 – showed strong tolerability and improvements in both spleen volume and symptoms of the condition over time.The data – to be presented at the 66th American Society of Hematology annual meeting  – was from Syntara’s Phase 2 clinical trial for the drug, which was tested in combination with ruxolitinib .It showed a 50% improvement in Total Symptom Score  among 46% of evaluable patients following 12 weeks of treatment, with this rising to an 80% improvement at 38 weeks of treatment.TSS50 is a standard efficacy endpoint used as the primary endpoint in clinical trials related to MF.The material provided in this article is for information only and should not be treated as investment advice. Viewers are encouraged to conduct their own research and consult with a certified financial advisor before making any investme","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://themarketonline.com.au/clinical-trial-data-for-mf-candidate-proves-promising-for-syntara-2024-12-10/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"markerherald_stock","symbols":["BK4563","BK7133","ASH","BK4539","BK4526","BK7164","SRV","MF","SRV.AU","BK4113","BK7057","SNT.AU","BK7096","LU2463526074.USD","ASH.AU","BK4109"],"gpt_icon":0},{"id":"2490030358","title":"Metagenomi presents updated preclinical data in Hemophilia A at ASH","url":"https://stock-news.laohu8.com/highlight/detail?id=2490030358","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490030358?lang=en_us&edition=fundamental","pubTime":"2024-12-10 10:50","pubTimestamp":1733799022,"startTime":"0","endTime":"0","summary":"The company states: “Metagenomi (MGX) presented updated preclinical NHP data for its hemophilia A program in an oral presentation (link here) at th...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/metagenomi-presents-updated-preclinical-data-in-hemophilia-a-at-ash?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/metagenomi-presents-updated-preclinical-data-in-hemophilia-a-at-ash?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MGX","BK4109","LU2463526074.USD","ASH","BK4139"],"gpt_icon":0},{"id":"2490032176","title":"Metagenomi Presents Updated Preclinical Data in Hemophilia A at American Society of Hematology (ASH) 66th Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2490032176","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490032176?lang=en_us&edition=fundamental","pubTime":"2024-12-10 10:16","pubTimestamp":1733796960,"startTime":"0","endTime":"0","summary":"Therapeutically relevant levels of Factor VIII (FVIII) activity sustained in ongoing nonhuman primate (NHP) study through more than sixteen months of follow up  MGX-001 bioengineered FVIII construct e","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/12/10/2994179/0/en/Metagenomi-Presents-Updated-Preclinical-Data-in-Hemophilia-A-at-American-Society-of-Hematology-ASH-66th-Annual-Meeting.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4109","WFH","BK4117","BK4139","ASH","LU2463526074.USD","MGX","AFG","BK4107"],"gpt_icon":0},{"id":"2490349860","title":"Lyell Presents Positive Initial Clinical Data from the Phase 1-2 Clinical Trial of IMPT-314 for the Treatment of B-cell Lymphoma at the 2024 ASH Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2490349860","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490349860?lang=en_us&edition=fundamental","pubTime":"2024-12-10 10:00","pubTimestamp":1733796000,"startTime":"0","endTime":"0","summary":"Objective response rate (ORR) of 94% and a complete response (CR) rate of 71% demonstrated after IMPT-314 treatment in CAR T-nave patients with large B-cell lymphoma who had received at least 2 prior ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2024/12/10/2994158/0/en/Lyell-Presents-Positive-Initial-Clinical-Data-from-the-Phase-1-2-Clinical-Trial-of-IMPT-314-for-the-Treatment-of-B-cell-Lymphoma-at-the-2024-ASH-Annual-Meeting.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4022","LU2463526074.USD","CRS","CAR","IE0031619046.USD","IE00B7SZL793.SGD","BK4230","CR","IE00B19Z4B17.USD","BK4161","BK4109","ASH","IE00B66KJ199.SGD","BK4006"],"gpt_icon":0},{"id":"2490603952","title":"BeiGene discloses new data in BRUKINSA, promising advancements pipeline at ASH","url":"https://stock-news.laohu8.com/highlight/detail?id=2490603952","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490603952?lang=en_us&edition=fundamental","pubTime":"2024-12-10 09:35","pubTimestamp":1733794543,"startTime":"0","endTime":"0","summary":"BeiGene (BGNE) “announced the presentation of new clinical data at the 66th American Society of Hematology Annual Meeting and Exposition, underscor...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/beigene-discloses-new-data-in-brukinsa-promising-advancements-pipeline-at-ash?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/beigene-discloses-new-data-in-brukinsa-promising-advancements-pipeline-at-ash?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4504","BK4505","BK4109","LU2463526074.USD","BK4526","BK4139","ASH","BK4585","BK4535","BK4548","BK4588","BGNE"],"gpt_icon":0},{"id":"2490358700","title":"Keros Therapeutics presents clinical data from Elritercept program at ASH","url":"https://stock-news.laohu8.com/highlight/detail?id=2490358700","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490358700?lang=en_us&edition=fundamental","pubTime":"2024-12-10 08:45","pubTimestamp":1733791509,"startTime":"0","endTime":"0","summary":"The company states: “Keros Therapeutics (KROS) announced that it presented additional data from its two ongoing Phase 2 clinical trials of elriterc...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/keros-therapeutics-presents-clinical-data-from-elritercept-program-at-ash?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/keros-therapeutics-presents-clinical-data-from-elritercept-program-at-ash?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["KROS","BK4139","LENZ","BK4109","ASH","LU2463526074.USD"],"gpt_icon":0},{"id":"2490035813","title":"Genentech presents updated fixed-duration Columvi and Lunsumio data at ASH","url":"https://stock-news.laohu8.com/highlight/detail?id=2490035813","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490035813?lang=en_us&edition=fundamental","pubTime":"2024-12-10 08:40","pubTimestamp":1733791210,"startTime":"0","endTime":"0","summary":"The company states: “Genentech, a member of the Roche (RHHBY) Group, announced that new and updated data from its industry-leading CD20xCD3 T-cell-...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/genentech-presents-updated-fixed-duration-columvi-and-lunsumio-data-at-ash?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/genentech-presents-updated-fixed-duration-columvi-and-lunsumio-data-at-ash?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2463526074.USD","BK4109","BK4007","03165","ASH","RHHBY"],"gpt_icon":0},{"id":"2490035873","title":"Autolus Therapeutics presents clinical data updates at ASH meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2490035873","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490035873?lang=en_us&edition=fundamental","pubTime":"2024-12-10 08:36","pubTimestamp":1733790995,"startTime":"0","endTime":"0","summary":"Autolus Therapeutics (AUTL) announces an oral presentation and three poster presentations at the American Society of Hematology Annual Meeting, bei...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/autolus-therapeutics-presents-clinical-data-updates-at-ash-meeting?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/autolus-therapeutics-presents-clinical-data-updates-at-ash-meeting?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2463526074.USD","ASH","AUTL","BK4109","BK4139","LENZ"],"gpt_icon":0},{"id":"2490055788","title":"Is Ashley Services Group (ASX:ASH) A Risky Investment?","url":"https://stock-news.laohu8.com/highlight/detail?id=2490055788","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490055788?lang=en_us&edition=fundamental","pubTime":"2024-12-10 07:33","pubTimestamp":1733787206,"startTime":"0","endTime":"0","summary":"Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/9612011-choice1-main-header/1585186854967","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9612011-choice1-main-header/1585186854967"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/commercial-services/asx-ash/ashley-services-group-shares/news/is-ashley-services-group-asxash-a-risky-investment","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["ASH.AU","BK4109","BK7057","LU2463526074.USD","ASH","EBIT"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":7,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ASH\",params:#limit:5,,,undefined,":[{"date":"2025-04-30","symbol":"ASH","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2025/03","expectedEps":1.14,"defaultRemindTime":1746043200000,"name":null,"time":"Post Market","dateTimestamp":1745985600000,"actualEps":null},{"date":"2025-02-28","symbol":"ASH","amount":0.405,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-01","defaultRemindTime":1740753000000,"name":"亚什兰","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-15","payableDate":"2025-03-01","currency":"USD","dateTimestamp":1740718800000,"payDate":"2025-03-15"},{"market":"US","date":"2025-01-28","symbol":"ASH","fiscalQuarterEnding":"2024/12","expectedEps":0.2,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1738040400000,"reportTimeType":"post","actualEps":0.28},{"date":"2024-11-29","symbol":"ASH","amount":0.405,"announcedDate":"2024-11-14","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-01","defaultRemindTime":1732890600000,"name":"亚什兰","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-15","payableDate":"2024-12-01","currency":"USD","dateTimestamp":1732856400000,"payDate":"2024-12-15"},{"market":"US","date":"2024-11-06","symbol":"ASH","fiscalQuarterEnding":"2024/09","expectedEps":1.33,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1730869200000,"reportTimeType":"post","actualEps":1.26}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ASH\",market:\"US\",,,undefined,":[{"executeDate":"2015-05-27","recordDate":"2015-05-29","paymentDate":"2015-06-15","value":0.39,"currency":"USD"},{"executeDate":"2015-08-19","recordDate":"2015-08-21","paymentDate":"2015-09-15","value":0.39,"currency":"USD"},{"executeDate":"2015-11-27","recordDate":"2015-12-01","paymentDate":"2015-12-15","value":0.39,"currency":"USD"},{"executeDate":"2016-02-17","recordDate":"2016-02-19","paymentDate":"2016-03-15","value":0.39,"currency":"USD"},{"executeDate":"2016-06-01","recordDate":"2016-06-03","paymentDate":"2016-06-15","value":0.39,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ASH\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2727,"buy":0.4545,"hold":0.2727,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.4545,"analysts":11,"updateTime":1743048000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ASH\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ASH","date":"2025-04-17","current":-106.268673,"percent":0.042184,"low":-152.607239,"twenty":-10.617545,"median":17.86146,"eighty":27.96106,"high":41.666396,"avg":3.080485,"sd":37.618835,"marketCap":2337910812},"quantilePoints":[{"date":"2020-04-24","current":5.830102,"twenty":10.902122,"median":16.855926,"eighty":45.060758,"marketCap":3410609559},{"date":"2020-05-01","current":6.059763,"twenty":10.78415,"median":16.855926,"eighty":45.060758,"marketCap":3544961429},{"date":"2020-05-08","current":-51.569829,"twenty":10.709199,"median":16.855926,"eighty":45.060758,"marketCap":3764597548},{"date":"2020-05-15","current":-48.919702,"twenty":10.615504,"median":16.855926,"eighty":45.060758,"marketCap":3571138223},{"date":"2020-05-22","current":-52.571909,"twenty":9.138439,"median":16.855926,"eighty":45.060758,"marketCap":3837749355},{"date":"2020-05-29","current":-55.619556,"twenty":9.120788,"median":16.855926,"eighty":45.060758,"marketCap":4060227579},{"date":"2020-06-05","current":-59.636156,"twenty":9.07954,"median":16.855926,"eighty":45.060758,"marketCap":4353439368},{"date":"2020-06-12","current":-55.13922,"twenty":9.032533,"median":16.855926,"eighty":45.060758,"marketCap":4025163076},{"date":"2020-06-19","current":-56.936338,"twenty":8.983635,"median":16.855926,"eighty":45.060758,"marketCap":4156352681},{"date":"2020-06-26","current":-55.08953,"twenty":8.930444,"median":16.855926,"eighty":45.060758,"marketCap":4021535714},{"date":"2020-07-02","current":-57.723095,"twenty":8.872607,"median":16.855926,"eighty":45.060758,"marketCap":4213785918},{"date":"2020-07-10","current":-57.093689,"twenty":8.675995,"median":16.855926,"eighty":45.060758,"marketCap":4167839328},{"date":"2020-07-17","current":-63.354616,"twenty":8.557057,"median":16.855926,"eighty":45.060758,"marketCap":4624886983},{"date":"2020-07-24","current":-64.439512,"twenty":8.367293,"median":16.855926,"eighty":45.060758,"marketCap":4704084394},{"date":"2020-07-31","current":-44.748169,"twenty":8.317859,"median":16.855926,"eighty":45.060758,"marketCap":4564313264},{"date":"2020-08-07","current":-47.060277,"twenty":8.104676,"median":16.855926,"eighty":45.060758,"marketCap":4800148210},{"date":"2020-08-14","current":-45.655227,"twenty":7.849302,"median":16.855926,"eighty":45.060758,"marketCap":4656833127},{"date":"2020-08-21","current":-44.599957,"twenty":7.651738,"median":16.855926,"eighty":45.060758,"marketCap":4549195639},{"date":"2020-08-28","current":-44.718527,"twenty":7.25977,"median":16.855926,"eighty":45.060758,"marketCap":4561289739},{"date":"2020-09-04","current":-44.196821,"twenty":6.363575,"median":16.855926,"eighty":45.060758,"marketCap":4508075700},{"date":"2020-09-11","current":-43.260121,"twenty":6.075417,"median":16.855926,"eighty":45.060758,"marketCap":4412532312},{"date":"2020-09-18","current":-42.133709,"twenty":5.834015,"median":16.855926,"eighty":45.060758,"marketCap":4297638363},{"date":"2020-09-25","current":-41.013227,"twenty":5.699102,"median":16.855926,"eighty":45.060758,"marketCap":4183349120},{"date":"2020-10-02","current":-42.044782,"twenty":5.471088,"median":16.855926,"eighty":45.060758,"marketCap":4288567789},{"date":"2020-10-09","current":-44.101965,"twenty":5.216092,"median":16.855926,"eighty":45.060758,"marketCap":4498400420},{"date":"2020-10-16","current":-45.258019,"twenty":4.885092,"median":16.855926,"eighty":45.060758,"marketCap":4616317893},{"date":"2020-10-23","current":-44.754098,"twenty":4.479735,"median":16.855926,"eighty":45.060758,"marketCap":4564917969},{"date":"2020-10-30","current":-41.363007,"twenty":-40.555548,"median":16.855926,"eighty":45.060758,"marketCap":4219026715},{"date":"2020-11-06","current":-44.754098,"twenty":-41.328622,"median":16.855926,"eighty":45.060758,"marketCap":4564917969},{"date":"2020-11-13","current":-9.712181,"twenty":-41.685517,"median":16.855926,"eighty":45.060758,"marketCap":4933788013},{"date":"2020-11-20","current":-9.201515,"twenty":-41.685517,"median":16.855926,"eighty":45.060758,"marketCap":4674369572},{"date":"2020-11-27","current":-9.108247,"twenty":-41.685517,"median":16.855926,"eighty":45.060758,"marketCap":4626989343},{"date":"2020-12-04","current":-8.938913,"twenty":-41.685517,"median":16.855926,"eighty":45.060758,"marketCap":4540967808},{"date":"2020-12-11","current":-9.025329,"twenty":-41.685517,"median":16.855926,"eighty":45.060758,"marketCap":4584867159},{"date":"2020-12-18","current":-9.373926,"twenty":-41.685517,"median":16.855926,"eighty":45.060758,"marketCap":4761954621},{"date":"2020-12-24","current":-9.457494,"twenty":-41.685517,"median":16.855926,"eighty":45.060758,"marketCap":4804407095},{"date":"2020-12-31","current":-9.455107,"twenty":-41.685517,"median":16.855926,"eighty":45.060758,"marketCap":4803194167},{"date":"2021-01-08","current":-10.356446,"twenty":-41.685517,"median":16.855926,"eighty":45.060758,"marketCap":5261074419},{"date":"2021-01-15","current":-10.145138,"twenty":-41.685517,"median":16.855926,"eighty":45.060758,"marketCap":5153730307},{"date":"2021-01-22","current":-10.225125,"twenty":-41.685517,"median":16.855926,"eighty":45.060758,"marketCap":5194363389},{"date":"2021-01-29","current":-9.549419,"twenty":-41.685517,"median":16.84568,"eighty":45.060758,"marketCap":4851104816},{"date":"2021-02-05","current":-10.650636,"twenty":-41.685517,"median":16.798842,"eighty":45.060758,"marketCap":5154907958},{"date":"2021-02-12","current":-10.819853,"twenty":-41.685517,"median":16.763713,"eighty":45.060758,"marketCap":5236808932},{"date":"2021-02-19","current":-10.931411,"twenty":-41.685517,"median":16.727121,"eighty":45.060758,"marketCap":5290802907},{"date":"2021-02-26","current":-10.544092,"twenty":-41.685517,"median":16.708151,"eighty":45.060758,"marketCap":5103340678},{"date":"2021-03-05","current":-10.893807,"twenty":-41.766144,"median":16.655852,"eighty":45.067329,"marketCap":5272602691},{"date":"2021-03-12","current":-11.366361,"twenty":-41.766144,"median":16.626772,"eighty":45.067329,"marketCap":5501318743},{"date":"2021-03-19","current":-11.074305,"twenty":-41.766144,"median":16.605449,"eighty":45.067329,"marketCap":5359963729},{"date":"2021-03-26","current":-11.298674,"twenty":-41.685517,"median":16.565507,"eighty":45.060758,"marketCap":5468558354},{"date":"2021-04-01","current":-11.32625,"twenty":-41.685517,"median":16.544159,"eighty":45.032615,"marketCap":5481905179},{"date":"2021-04-09","current":-11.130711,"twenty":-41.766144,"median":16.513421,"eighty":45.025182,"marketCap":5387264054},{"date":"2021-04-16","current":-11.373882,"twenty":-41.766144,"median":16.49824,"eighty":44.88663,"marketCap":5504958787},{"date":"2021-04-23","current":-11.615799,"twenty":-41.766144,"median":16.458163,"eighty":44.798223,"marketCap":5622046845},{"date":"2021-04-30","current":37.652621,"twenty":-41.766144,"median":16.458163,"eighty":44.763306,"marketCap":5233714269},{"date":"2021-05-07","current":38.556703,"twenty":-41.766144,"median":16.48927,"eighty":44.763306,"marketCap":5359381692},{"date":"2021-05-14","current":38.897371,"twenty":-41.766144,"median":16.508117,"eighty":44.763306,"marketCap":5406734634},{"date":"2021-05-21","current":38.897371,"twenty":-41.766144,"median":16.532217,"eighty":44.763306,"marketCap":5406734634},{"date":"2021-05-28","current":41.421813,"twenty":-41.766144,"median":16.539302,"eighty":44.763306,"marketCap":5757632076},{"date":"2021-06-04","current":41.177231,"twenty":-41.766144,"median":16.551203,"eighty":44.763306,"marketCap":5723635092},{"date":"2021-06-11","current":40.923913,"twenty":-41.766144,"median":16.551203,"eighty":44.763306,"marketCap":5688423930},{"date":"2021-06-18","current":38.067538,"twenty":-41.766144,"median":16.551203,"eighty":44.763306,"marketCap":5291387724},{"date":"2021-06-25","current":38.72267,"twenty":-41.766144,"median":16.559996,"eighty":44.763306,"marketCap":5382451074},{"date":"2021-07-02","current":38.32959,"twenty":-41.766144,"median":16.589527,"eighty":44.763306,"marketCap":5327813064},{"date":"2021-07-09","current":38.399471,"twenty":-41.766144,"median":16.609898,"eighty":44.763306,"marketCap":5337526488},{"date":"2021-07-16","current":37.713766,"twenty":-41.766144,"median":16.609898,"eighty":44.763306,"marketCap":5242213515},{"date":"2021-07-23","current":38.233504,"twenty":-41.766144,"median":16.609898,"eighty":44.763306,"marketCap":5314457106},{"date":"2021-07-30","current":28.544675,"twenty":-41.766144,"median":16.63409,"eighty":44.763306,"marketCap":5166586254},{"date":"2021-08-06","current":28.329928,"twenty":-41.766144,"median":16.642592,"eighty":44.763306,"marketCap":5127716909},{"date":"2021-08-13","current":29.118455,"twenty":-41.766144,"median":16.707431,"eighty":44.763306,"marketCap":5270440286},{"date":"2021-08-20","current":28.051427,"twenty":-41.766144,"median":16.798988,"eighty":44.763306,"marketCap":5077308227},{"date":"2021-08-27","current":29.259383,"twenty":-41.766144,"median":16.876011,"eighty":44.763306,"marketCap":5295948294},{"date":"2021-09-03","current":31.51759,"twenty":-41.685517,"median":16.928602,"eighty":44.762757,"marketCap":5704683753},{"date":"2021-09-10","current":31.051184,"twenty":-41.685517,"median":16.94157,"eighty":44.762757,"marketCap":5620264394},{"date":"2021-09-17","current":30.272724,"twenty":-41.685517,"median":16.987677,"eighty":44.762757,"marketCap":5479363017},{"date":"2021-09-24","current":31.121649,"twenty":-41.685517,"median":16.987677,"eighty":44.762757,"marketCap":5633018398},{"date":"2021-10-01","current":30.59149,"twenty":-41.685517,"median":19.684212,"eighty":44.762757,"marketCap":5537059701},{"date":"2021-10-08","current":31.071317,"twenty":-41.685517,"median":19.787677,"eighty":44.762757,"marketCap":5623908395},{"date":"2021-10-15","current":32.124923,"twenty":-41.685517,"median":19.83941,"eighty":44.762757,"marketCap":5814611120},{"date":"2021-10-22","current":32.826209,"twenty":-41.685517,"median":19.917009,"eighty":44.762757,"marketCap":5941543826},{"date":"2021-10-29","current":32.21552,"twenty":-41.604889,"median":19.999764,"eighty":44.762207,"marketCap":5831009125},{"date":"2021-11-05","current":32.916806,"twenty":-41.604889,"median":20.15896,"eighty":44.762207,"marketCap":5957941831},{"date":"2021-11-12","current":29.342491,"twenty":-41.604889,"median":20.28364,"eighty":44.762207,"marketCap":6455347984},{"date":"2021-11-19","current":30.162391,"twenty":-41.604889,"median":20.500749,"eighty":44.762207,"marketCap":6635726039},{"date":"2021-11-26","current":26.923508,"twenty":-41.604889,"median":20.528215,"eighty":44.762207,"marketCap":5923171764},{"date":"2021-12-03","current":26.411959,"twenty":-41.604889,"median":20.552965,"eighty":44.762207,"marketCap":5810630932},{"date":"2021-12-10","current":27.165993,"twenty":-41.604889,"median":20.676932,"eighty":44.762207,"marketCap":5976518382},{"date":"2021-12-17","current":26.837476,"twenty":-41.604889,"median":20.708356,"eighty":44.762207,"marketCap":5904244736},{"date":"2021-12-23","current":26.982334,"twenty":-41.604889,"median":20.728755,"eighty":44.762207,"marketCap":5936113430},{"date":"2021-12-31","current":27.848893,"twenty":-41.604889,"median":20.764302,"eighty":44.762207,"marketCap":6126756513},{"date":"2022-01-07","current":26.876277,"twenty":-41.524262,"median":20.796751,"eighty":44.761658,"marketCap":5912780993},{"date":"2022-01-14","current":27.341891,"twenty":-41.524262,"median":20.868148,"eighty":44.761658,"marketCap":6015216083},{"date":"2022-01-21","current":25.013821,"twenty":-41.524262,"median":20.917445,"eighty":44.761658,"marketCap":5503040636},{"date":"2022-01-28","current":24.677544,"twenty":-41.524262,"median":20.980342,"eighty":44.761658,"marketCap":5429059738},{"date":"2022-02-04","current":25.572734,"twenty":-41.443634,"median":21.023702,"eighty":44.761108,"marketCap":5421419569},{"date":"2022-02-11","current":25.553938,"twenty":-41.443634,"median":21.065338,"eighty":44.761108,"marketCap":5417434905},{"date":"2022-02-18","current":25.494866,"twenty":-41.443634,"median":21.115412,"eighty":44.761108,"marketCap":5404911676},{"date":"2022-02-25","current":25.29617,"twenty":-41.443634,"median":21.157984,"eighty":44.761108,"marketCap":5362788089},{"date":"2022-03-04","current":23.572347,"twenty":-41.443634,"median":21.240692,"eighty":44.761108,"marketCap":4997337504},{"date":"2022-03-11","current":23.66901,"twenty":-41.443634,"median":21.332705,"eighty":44.761108,"marketCap":5017830061},{"date":"2022-03-18","current":25.352557,"twenty":-41.443634,"median":21.402701,"eighty":44.761108,"marketCap":5374742080},{"date":"2022-03-25","current":26.448071,"twenty":-41.443634,"median":21.507199,"eighty":44.761108,"marketCap":5606991049},{"date":"2022-04-01","current":26.544734,"twenty":-41.443634,"median":21.611248,"eighty":44.761108,"marketCap":5627483605},{"date":"2022-04-08","current":26.703154,"twenty":-41.443634,"median":21.681627,"eighty":44.761108,"marketCap":5661068628},{"date":"2022-04-14","current":28.520955,"twenty":-41.443634,"median":21.86021,"eighty":44.761108,"marketCap":6046442530},{"date":"2022-04-22","current":27.734226,"twenty":-41.443634,"median":22.114023,"eighty":44.761108,"marketCap":5879655893},{"date":"2022-04-29","current":5.98168,"twenty":-41.443634,"median":22.157672,"eighty":44.761108,"marketCap":5724467780},{"date":"2022-05-06","current":5.79477,"twenty":-41.443634,"median":22.157672,"eighty":44.761108,"marketCap":5545595204},{"date":"2022-05-13","current":5.627805,"twenty":-41.443634,"median":22.157672,"eighty":44.761108,"marketCap":5385809640},{"date":"2022-05-20","current":5.695617,"twenty":-41.443634,"median":22.157672,"eighty":44.761108,"marketCap":5450705483},{"date":"2022-05-27","current":6.155649,"twenty":-41.443634,"median":22.157672,"eighty":44.761108,"marketCap":5890955748},{"date":"2022-06-03","current":6.053281,"twenty":-41.443634,"median":22.157672,"eighty":44.761108,"marketCap":5792989652},{"date":"2022-06-10","current":5.809521,"twenty":-41.443634,"median":22.157672,"eighty":44.761108,"marketCap":5559711268},{"date":"2022-06-17","current":5.398352,"twenty":-41.443634,"median":22.157672,"eighty":44.761108,"marketCap":5166223136},{"date":"2022-06-24","current":5.835537,"twenty":-41.524262,"median":22.199705,"eighty":44.761658,"marketCap":5584608729},{"date":"2022-07-01","current":5.86325,"twenty":-41.524262,"median":22.199705,"eighty":44.761658,"marketCap":5611129938},{"date":"2022-07-08","current":5.737128,"twenty":-41.524262,"median":22.199705,"eighty":44.761658,"marketCap":5490431377},{"date":"2022-07-15","current":5.58499,"twenty":-41.524262,"median":22.199705,"eighty":44.761658,"marketCap":5344835356},{"date":"2022-07-22","current":5.922634,"twenty":-41.524262,"median":22.199705,"eighty":44.761658,"marketCap":5667961098},{"date":"2022-07-29","current":5.951187,"twenty":-41.524262,"median":22.199705,"eighty":44.761658,"marketCap":5439385116},{"date":"2022-08-05","current":6.14725,"twenty":-41.524262,"median":22.199705,"eighty":44.761658,"marketCap":5618586516},{"date":"2022-08-12","current":6.304219,"twenty":-41.524262,"median":22.199705,"eighty":44.761658,"marketCap":5762055916},{"date":"2022-08-19","current":6.275787,"twenty":-41.524262,"median":22.199705,"eighty":44.761658,"marketCap":5736069006},{"date":"2022-08-26","current":6.098679,"twenty":-41.524262,"median":22.199705,"eighty":44.761658,"marketCap":5574192212},{"date":"2022-09-02","current":5.884253,"twenty":-41.524262,"median":22.199705,"eighty":44.761658,"marketCap":5378207598},{"date":"2022-09-09","current":6.054846,"twenty":-41.524262,"median":22.199705,"eighty":44.761658,"marketCap":5534129059},{"date":"2022-09-16","current":5.848121,"twenty":-41.524262,"median":22.199705,"eighty":44.761658,"marketCap":5345182567},{"date":"2022-09-23","current":5.752755,"twenty":-41.524262,"median":22.199705,"eighty":44.761658,"marketCap":5258018139},{"date":"2022-09-30","current":5.625403,"twenty":-41.524262,"median":22.199705,"eighty":44.761658,"marketCap":5141618438},{"date":"2022-10-07","current":5.617703,"twenty":-41.524262,"median":22.199705,"eighty":44.761658,"marketCap":5134580316},{"date":"2022-10-14","current":5.641396,"twenty":-41.524262,"median":22.199705,"eighty":44.761658,"marketCap":5156236075},{"date":"2022-10-21","current":5.922755,"twenty":-41.524262,"median":22.199705,"eighty":44.761658,"marketCap":5413398206},{"date":"2022-10-28","current":6.27401,"twenty":-41.524262,"median":22.199705,"eighty":44.761658,"marketCap":5734444824},{"date":"2022-11-04","current":5.909724,"twenty":-41.524262,"median":21.695313,"eighty":44.761658,"marketCap":5401487538},{"date":"2022-11-11","current":6.292902,"twenty":-41.524262,"median":21.556282,"eighty":44.761658,"marketCap":5833519919},{"date":"2022-11-18","current":6.534105,"twenty":-41.524262,"median":9.134384,"eighty":44.761658,"marketCap":6057115624},{"date":"2022-11-25","current":6.524573,"twenty":-41.524262,"median":9.120072,"eighty":44.761658,"marketCap":6048278877},{"date":"2022-12-02","current":6.634386,"twenty":-41.524262,"median":9.077138,"eighty":44.761658,"marketCap":6150076230},{"date":"2022-12-09","current":6.425327,"twenty":-41.524262,"median":9.031818,"eighty":44.761658,"marketCap":5956278049},{"date":"2022-12-16","current":6.216944,"twenty":-41.524262,"median":8.981727,"eighty":44.761658,"marketCap":5763107329},{"date":"2022-12-23","current":6.332842,"twenty":-41.524262,"median":8.929251,"eighty":44.761658,"marketCap":5870544977},{"date":"2022-12-30","current":6.29421,"twenty":-41.524262,"median":8.870812,"eighty":44.761658,"marketCap":5834732428},{"date":"2023-01-06","current":6.238017,"twenty":-41.524262,"median":8.723665,"eighty":44.669031,"marketCap":5782641447},{"date":"2023-01-13","current":6.570492,"twenty":-41.524262,"median":8.558011,"eighty":44.528495,"marketCap":6090846415},{"date":"2023-01-20","current":6.436448,"twenty":-41.524262,"median":8.531792,"eighty":44.433823,"marketCap":5966587722},{"date":"2023-01-27","current":6.301234,"twenty":-41.524262,"median":8.3296,"eighty":44.14834,"marketCap":5841243800},{"date":"2023-02-03","current":6.219087,"twenty":-40.702575,"median":8.3296,"eighty":44.14834,"marketCap":5715340826},{"date":"2023-02-10","current":6.142315,"twenty":-11.558641,"median":8.3296,"eighty":44.14834,"marketCap":5644787763},{"date":"2023-02-17","current":6.10452,"twenty":-11.342294,"median":8.3296,"eighty":44.14834,"marketCap":5610053948},{"date":"2023-02-24","current":6.038378,"twenty":-11.297421,"median":8.3296,"eighty":44.14834,"marketCap":5549269770},{"date":"2023-03-03","current":6.122827,"twenty":-11.1811,"median":8.3296,"eighty":44.14834,"marketCap":5626878140},{"date":"2023-03-10","current":5.75019,"twenty":-11.13773,"median":8.3296,"eighty":44.14834,"marketCap":5284424426},{"date":"2023-03-17","current":5.610229,"twenty":-11.066032,"median":8.3296,"eighty":44.14834,"marketCap":5155800765},{"date":"2023-03-24","current":5.809835,"twenty":-10.976285,"median":8.3296,"eighty":44.14834,"marketCap":5339238729},{"date":"2023-03-31","current":6.065544,"twenty":-10.897567,"median":8.324965,"eighty":44.139273,"marketCap":5574234700},{"date":"2023-04-06","current":5.988772,"twenty":-10.820856,"median":8.324965,"eighty":44.139273,"marketCap":5503681637},{"date":"2023-04-14","current":6.134638,"twenty":-10.775982,"median":8.3296,"eighty":44.14834,"marketCap":5637732457},{"date":"2023-04-21","current":6.151764,"twenty":-10.730374,"median":8.3296,"eighty":44.14834,"marketCap":5653471217},{"date":"2023-04-27","current":5.856489,"twenty":-10.606264,"median":8.340928,"eighty":44.166474,"marketCap":5382113282},{"date":"2023-05-05","current":20.861975,"twenty":-10.43882,"median":8.452838,"eighty":44.175541,"marketCap":4693944269},{"date":"2023-05-12","current":20.287633,"twenty":-10.336151,"median":8.558011,"eighty":44.182524,"marketCap":4564717446},{"date":"2023-05-19","current":21.14158,"twenty":-10.102877,"median":8.693871,"eighty":44.189507,"marketCap":4756855455},{"date":"2023-05-26","current":20.227136,"twenty":-9.78508,"median":8.870812,"eighty":44.196491,"marketCap":4551105489},{"date":"2023-06-02","current":19.892072,"twenty":-9.536436,"median":8.929251,"eighty":44.196491,"marketCap":4475716188},{"date":"2023-06-09","current":20.206194,"twenty":-9.454384,"median":8.98113,"eighty":44.203474,"marketCap":4546393658},{"date":"2023-06-16","current":20.073565,"twenty":-9.376314,"median":9.018699,"eighty":44.210457,"marketCap":4516552059},{"date":"2023-06-23","current":19.475569,"twenty":-9.301666,"median":9.056863,"eighty":44.224123,"marketCap":4382003099},{"date":"2023-06-29","current":19.508145,"twenty":-9.246426,"median":9.092642,"eighty":44.237789,"marketCap":4389332615},{"date":"2023-07-05","current":20.315555,"twenty":-9.193781,"median":9.114705,"eighty":44.251456,"marketCap":4570999888},{"date":"2023-07-14","current":20.455165,"twenty":-9.060547,"median":9.163604,"eighty":44.278788,"marketCap":4602412096},{"date":"2023-07-20","current":21.216038,"twenty":-8.93818,"median":19.183552,"eighty":44.278788,"marketCap":4773608633},{"date":"2023-07-28","current":19.591649,"twenty":4.319692,"median":19.750135,"eighty":44.283744,"marketCap":4682404042},{"date":"2023-08-04","current":19.289348,"twenty":4.38581,"median":19.591649,"eighty":44.129229,"marketCap":4610154209},{"date":"2023-08-11","current":19.13927,"twenty":4.38581,"median":19.482306,"eighty":43.956729,"marketCap":4574285498},{"date":"2023-08-18","current":18.466062,"twenty":4.38581,"median":19.154278,"eighty":43.542383,"marketCap":4413388708},{"date":"2023-08-25","current":18.088722,"twenty":4.38581,"median":18.641868,"eighty":43.319191,"marketCap":4323204519},{"date":"2023-08-31","current":18.781226,"twenty":4.38581,"median":18.466062,"eighty":42.973946,"marketCap":4488713001},{"date":"2023-09-08","current":17.87218,"twenty":4.380867,"median":18.294543,"eighty":42.623722,"marketCap":4271451093},{"date":"2023-09-13","current":17.293307,"twenty":4.378395,"median":18.166977,"eighty":42.388429,"marketCap":4133100350},{"date":"2023-09-22","current":18.005107,"twenty":4.319692,"median":17.86146,"eighty":42.077012,"marketCap":4303220523},{"date":"2023-09-29","current":17.479833,"twenty":4.263461,"median":17.50556,"eighty":41.816324,"marketCap":4177680034},{"date":"2023-10-06","current":17.087485,"twenty":4.263461,"median":17.293307,"eighty":41.73771,"marketCap":4083908975},{"date":"2023-10-13","current":16.418565,"twenty":4.263461,"median":16.945983,"eighty":41.577207,"marketCap":3924037005},{"date":"2023-10-20","current":16.294214,"twenty":4.207231,"median":16.495748,"eighty":41.332109,"marketCap":3894317216},{"date":"2023-10-27","current":16.257767,"twenty":-1.056217,"median":16.28671,"eighty":41.192954,"marketCap":3885606243},{"date":"2023-11-03","current":16.332806,"twenty":-6.207204,"median":16.153784,"eighty":40.948113,"marketCap":3903540598},{"date":"2023-11-10","current":15.616718,"twenty":-6.207204,"median":15.881499,"eighty":40.817223,"marketCap":3732395605},{"date":"2023-11-17","current":16.390693,"twenty":-6.207204,"median":15.574911,"eighty":40.340898,"marketCap":3917375673},{"date":"2023-11-24","current":22.827913,"twenty":-6.207204,"median":15.574911,"eighty":39.96161,"marketCap":4063368468},{"date":"2023-12-01","current":23.015098,"twenty":-8.782697,"median":15.533103,"eighty":39.312288,"marketCap":4096687371},{"date":"2023-12-07","current":23.654406,"twenty":-6.207204,"median":15.574911,"eighty":38.926597,"marketCap":4210484243},{"date":"2023-12-15","current":24.893249,"twenty":-8.782697,"median":15.533103,"eighty":38.72267,"marketCap":4430998377},{"date":"2023-12-22","current":24.325418,"twenty":-8.782697,"median":15.533103,"eighty":38.648421,"marketCap":4329924480},{"date":"2023-12-29","current":24.225549,"twenty":-8.789917,"median":12.47951,"eighty":38.641433,"marketCap":4312147664},{"date":"2024-01-05","current":22.661874,"twenty":-8.797137,"median":9.425916,"eighty":38.597758,"marketCap":4033813516},{"date":"2024-01-12","current":23.423737,"twenty":-8.797137,"median":9.425916,"eighty":38.470225,"marketCap":4169425227},{"date":"2024-01-19","current":22.447867,"twenty":-8.804357,"median":9.30281,"eighty":38.332211,"marketCap":3995720339},{"date":"2024-01-26","current":22.718942,"twenty":-8.797137,"median":9.425916,"eighty":38.217781,"marketCap":4043971696},{"date":"2024-02-02","current":28.85349,"twenty":-8.797137,"median":9.425916,"eighty":38.049194,"marketCap":4731972377},{"date":"2024-02-09","current":27.918791,"twenty":-8.797137,"median":9.425916,"eighty":37.903318,"marketCap":4578681720},{"date":"2024-02-16","current":28.325049,"twenty":-8.797137,"median":9.425916,"eighty":37.631656,"marketCap":4645308051},{"date":"2024-02-23","current":28.413632,"twenty":-8.797137,"median":9.425916,"eighty":37.11978,"marketCap":4659835597},{"date":"2024-03-01","current":28.603015,"twenty":-8.789917,"median":12.47951,"eighty":32.879225,"marketCap":4690894489},{"date":"2024-03-08","current":29.339167,"twenty":-8.789917,"median":12.47951,"eighty":32.536971,"marketCap":4811623405},{"date":"2024-03-15","current":29.363604,"twenty":-8.789917,"median":12.47951,"eighty":32.258469,"marketCap":4815631004},{"date":"2024-03-22","current":29.357495,"twenty":-8.789917,"median":12.47951,"eighty":31.941046,"marketCap":4814629104},{"date":"2024-03-28","current":29.81568,"twenty":-8.789917,"median":12.47951,"eighty":31.40619,"marketCap":4889771583},{"date":"2024-04-05","current":29.122292,"twenty":-8.797137,"median":9.425916,"eighty":31.117622,"marketCap":4776055965},{"date":"2024-04-12","current":29.372767,"twenty":-8.797137,"median":9.425916,"eighty":31.051184,"marketCap":4817133853},{"date":"2024-04-19","current":29.168111,"twenty":-8.797137,"median":9.425916,"eighty":30.606254,"marketCap":4783570213},{"date":"2024-04-26","current":29.079528,"twenty":-8.789917,"median":12.47951,"eighty":30.256618,"marketCap":4769042667},{"date":"2024-05-03","current":24.879315,"twenty":-8.789917,"median":12.47951,"eighty":29.945905,"marketCap":4801707860},{"date":"2024-05-10","current":25.416952,"twenty":-8.789917,"median":12.47951,"eighty":29.757033,"marketCap":4905471669},{"date":"2024-05-17","current":25.614345,"twenty":-8.789917,"median":12.47951,"eighty":29.613467,"marketCap":4943568527},{"date":"2024-05-24","current":25.463703,"twenty":-8.789917,"median":12.47951,"eighty":29.5169,"marketCap":4914494609},{"date":"2024-05-31","current":25.87667,"twenty":-8.789917,"median":12.47951,"eighty":29.365437,"marketCap":4994197245},{"date":"2024-06-07","current":26.035104,"twenty":-8.789917,"median":12.47951,"eighty":29.342276,"marketCap":5024774986},{"date":"2024-06-14","current":25.292282,"twenty":-8.797137,"median":9.425916,"eighty":29.274986,"marketCap":4881410496},{"date":"2024-06-21","current":25.066319,"twenty":-8.804357,"median":9.30281,"eighty":29.230424,"marketCap":4837799620},{"date":"2024-06-28","current":24.487127,"twenty":-8.826676,"median":9.172548,"eighty":29.168722,"marketCap":4726015420},{"date":"2024-07-05","current":24.193634,"twenty":-8.826676,"median":9.172548,"eighty":29.132067,"marketCap":4669371408},{"date":"2024-07-12","current":24.601407,"twenty":-8.826676,"median":9.172548,"eighty":29.097856,"marketCap":4748071495},{"date":"2024-07-15","current":24.596212,"twenty":-8.826676,"median":9.172548,"eighty":29.090525,"marketCap":4747068946},{"date":"2024-08-02","current":24.957234,"twenty":-8.929025,"median":9.114705,"eighty":28.735731,"marketCap":4816746093},{"date":"2024-08-09","current":27.237695,"twenty":-8.929025,"median":9.114705,"eighty":28.677936,"marketCap":4058416549},{"date":"2024-08-16","current":27.91282,"twenty":-8.929025,"median":9.114705,"eighty":28.593851,"marketCap":4159010197},{"date":"2024-08-23","current":28.407693,"twenty":-8.929025,"median":9.114705,"eighty":28.535286,"marketCap":4232746318},{"date":"2024-08-30","current":29.413827,"twenty":-8.929025,"median":9.114705,"eighty":28.535286,"marketCap":4382660153},{"date":"2024-09-06","current":28.273324,"twenty":-8.929025,"median":9.114705,"eighty":28.515633,"marketCap":4212725252},{"date":"2024-09-13","current":27.91282,"twenty":-8.929025,"median":9.114705,"eighty":28.437936,"marketCap":4159010197},{"date":"2024-09-20","current":28.840298,"twenty":-8.929025,"median":9.114705,"eighty":28.414125,"marketCap":4297204384},{"date":"2024-09-27","current":28.584668,"twenty":-8.929025,"median":9.114705,"eighty":28.410315,"marketCap":4259115526},{"date":"2024-10-04","current":27.693241,"twenty":-8.929025,"median":9.114705,"eighty":28.328952,"marketCap":4126292846},{"date":"2024-10-11","current":27.781728,"twenty":-8.929025,"median":9.114705,"eighty":28.174035,"marketCap":4139477450},{"date":"2024-10-18","current":28.768197,"twenty":-8.929025,"median":9.114705,"eighty":28.155826,"marketCap":4286461373},{"date":"2024-10-25","current":27.847274,"twenty":-8.929025,"median":9.114705,"eighty":28.143107,"marketCap":4149243823},{"date":"2024-10-31","current":28.55845,"twenty":-8.929025,"median":9.114705,"eighty":28.102675,"marketCap":4255208977},{"date":"2024-11-08","current":23.317939,"twenty":-8.93818,"median":9.109339,"eighty":27.987673,"marketCap":3940731747},{"date":"2024-11-15","current":22.552233,"twenty":-8.93818,"median":9.109339,"eighty":27.96198,"marketCap":3811327297},{"date":"2024-11-22","current":21.642415,"twenty":-8.93818,"median":9.127228,"eighty":27.96083,"marketCap":3657568070},{"date":"2024-11-29","current":21.759491,"twenty":-8.93818,"median":9.172548,"eighty":27.96083,"marketCap":3677353987},{"date":"2024-12-06","current":21.310698,"twenty":-8.93818,"median":16.14628,"eighty":27.96083,"marketCap":3601507972},{"date":"2024-12-13","current":20.66399,"twenty":-8.93818,"median":16.326374,"eighty":27.96083,"marketCap":3492214336},{"date":"2024-12-20","current":20.056308,"twenty":-8.93818,"median":16.418565,"eighty":27.96083,"marketCap":3389516005},{"date":"2024-12-27","current":20.109271,"twenty":-8.93818,"median":16.564355,"eighty":27.96083,"marketCap":3398466777},{"date":"2025-01-03","current":19.440263,"twenty":-8.93818,"median":16.920255,"eighty":27.96083,"marketCap":3285404395},{"date":"2025-01-10","current":19.6399,"twenty":-8.938327,"median":17.089629,"eighty":27.96106,"marketCap":3319143109},{"date":"2025-01-17","current":19.75157,"twenty":-8.938327,"median":17.49484,"eighty":27.96106,"marketCap":3338015281},{"date":"2025-01-24","current":20.086579,"twenty":-8.938327,"median":17.759622,"eighty":27.96106,"marketCap":3394631794},{"date":"2025-01-31","current":-136.701619,"twenty":-9.032373,"median":17.86146,"eighty":27.96106,"marketCap":3007435623},{"date":"2025-02-07","current":-139.725612,"twenty":-9.144874,"median":17.86146,"eighty":27.96106,"marketCap":3073963459},{"date":"2025-02-14","current":-139.361017,"twenty":-9.245709,"median":17.86146,"eighty":27.96106,"marketCap":3065942372},{"date":"2025-02-21","current":-140.326121,"twenty":-9.301666,"median":17.86146,"eighty":27.96106,"marketCap":3087174660},{"date":"2025-02-28","current":-131.897546,"twenty":-9.377985,"median":17.86146,"eighty":27.96106,"marketCap":2901746013},{"date":"2025-03-07","current":-127.90845,"twenty":-9.455107,"median":17.87218,"eighty":27.96129,"marketCap":2813985889},{"date":"2025-03-14","current":-119.994597,"twenty":-9.579026,"median":17.87218,"eighty":27.96129,"marketCap":2639881128},{"date":"2025-03-21","current":-119.823023,"twenty":-9.954842,"median":17.87218,"eighty":27.96129,"marketCap":2636106499},{"date":"2025-03-28","current":-128.144364,"twenty":-10.210799,"median":17.87218,"eighty":27.96129,"marketCap":2819176004},{"date":"2025-04-04","current":-113.839378,"twenty":-10.377935,"median":17.87218,"eighty":27.96129,"marketCap":2504466314},{"date":"2025-04-11","current":-104.209785,"twenty":-10.499986,"median":17.86146,"eighty":27.96106,"marketCap":2292615264},{"date":"2025-04-17","current":-106.268673,"twenty":-10.617545,"median":17.86146,"eighty":27.96106,"marketCap":2337910812}],"updateTime":1745038071831}}}